Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (24)

2024

  1. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

2023

  1. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

    Pharmaceutics, Vol. 15, Núm. 10

  2. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)

    Bone Marrow Transplantation

2022

  1. Insights into the Pharmacokinetics and In Vitro Cell‐Based Studies of the Imidazoline I2 Receptor Ligand B06

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

2021

  1. BMP8 and activated brown adipose tissue in human newborns

    Nature Communications, Vol. 12, Núm. 1

  2. Virtual meeting, real and sound science: Report of the 17th Meeting of the Spanish Society for Developmental Biology (SEBD-2020)

    International Journal of Developmental Biology, Vol. 52

2019

  1. Bcl-x L inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Pharmacogenetics of ugt genes in North African populations

    Pharmacogenomics Journal

  2. UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data

    Annals of Human Biology, Vol. 45, Núm. 6-8, pp. 516-523

2017

  1. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1

    Cancer Letters, Vol. 386, pp. 196-207

  2. Improved selectivity and cytotoxic effects of irinotecan via liposomal delivery: A comparative study on Hs68 and HeLa cells

    European Journal of Pharmaceutical Sciences, Vol. 109, pp. 65-77

  3. Pharmacological tools based on imidazole scaffold proved the utility of PDE10A inhibitors for Parkinson's disease

    Future Medicinal Chemistry, Vol. 9, Núm. 8, pp. 731-748

2016

  1. Cytochrome and sulfotransferase gene variation in north African populations

    Pharmacogenomics, Vol. 17, Núm. 13, pp. 1415-1423

2015

  1. Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia

    International Journal of Biological Markers, Vol. 30, Núm. 1, pp. e148-e151

  2. North African genetic variation of cytochrome and sulfotransferase genes

    International Journal of Modern Anthropology, Vol. 1, Núm. 8, pp. 13

  3. The genotype of the donor for the (GT)n polymorphism in the promoter/enhancer of FOXP3 Is associated with the development of severe acute GVHD but does not affect the GVL effect after myeloablative HLA-Identical allogeneic stem cell transplantation

    PLoS ONE, Vol. 10, Núm. 10

2014

  1. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels

    Journal of Hematology and Oncology, Vol. 7, Núm. 1

2013

  1. A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT

    Bone Marrow Transplantation, Vol. 48, Núm. 9, pp. 1205-1211

2012

  1. Peroxisome proliferator-activated receptors-α and -γ and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue

    Endocrinology, Vol. 153, Núm. 3, pp. 1162-1173

2011

  1. Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: Involvement of PRDM16

    Journal of Biological Chemistry, Vol. 286, Núm. 50, pp. 43112-43122